Evidence map›Paper›PMID 35203773›Full record

ArticleAntibiotics (Basel, Switzerland)2022

Characterization and Antimicrobial Activity of

Salima Tiji, Mohammed Lakrat, Yahya Rokni, El Miloud Mejdoubi, Christophe Hano, Mohamed Addi, Abdeslam Asehraou, Mostafa Mimouni

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Potential of Secondary Metabolite Compounds of Black Cumin Seeds (Drug design, development and therapy · 2025
    Review
  3. Article
  4. Article
  5. Nanomaterials (Basel, Switzerland) · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Salima TijiApplied Chemistry and Environment Laboratory, Faculty of Sciences, Mohammed First University, Oujda 60000, Morocco.ORCID 0000-0003-1421-0546
Mohammed LakratSolid Mineral Chemistry Laboratory, Faculty of Sciences, Mohammed First University, Oujda 60000, Morocco.ORCID 0000-0003-2709-5989
Yahya RokniBio-Resources, Biotechnology, Ethno-Pharmacology and Health Laboratory, Faculty of Sciences, Mohammed First University, Oujda 60000, Morocco.ORCID 0000-0002-9590-9035
El Miloud MejdoubiSolid Mineral Chemistry Laboratory, Faculty of Sciences, Mohammed First University, Oujda 60000, Morocco.
Christophe HanoLaboratoire de Biologie des Ligneux et des Grandes Cultures, INRA USC1328, Orleans University, CEDEX 2, 45067 Orléans, France.ORCID 0000-0001-9938-0151
Mohamed AddiLaboratoire d'Amélioration des Productions Agricoles, Biotechnologie et Environnement (LAPABE), Faculté des Sciences, Université Mohammed Premier, Oujda 60000, Morocco.ORCID 0000-0002-3973-6694
Abdeslam AsehraouBio-Resources, Biotechnology, Ethno-Pharmacology and Health Laboratory, Faculty of Sciences, Mohammed First University, Oujda 60000, Morocco.ORCID 0000-0001-5195-8217
Mostafa MimouniApplied Chemistry and Environment Laboratory, Faculty of Sciences, Mohammed First University, Oujda 60000, Morocco.ORCID 0000-0002-9371-1439

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

antimicrobial activitycomposite scaffoldhydroxyapatiteNigella sativa L.

Identifiers

PMID35203773
PMCPMC8868394

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.